Marek Ziobro

712 total citations · 1 hit paper
46 papers, 457 citations indexed

About

Marek Ziobro is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marek Ziobro has authored 46 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marek Ziobro's work include Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and HER2/EGFR in Cancer Research (8 papers). Marek Ziobro is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and HER2/EGFR in Cancer Research (8 papers). Marek Ziobro collaborates with scholars based in Poland, Hungary and Spain. Marek Ziobro's co-authors include В. Б. Матвеев, Michael B. Atkins, Frede Donskov, Piotr Tomczak, Rustem Gafanov, Paweł Wiechno, Rodolfo F. Perini, David F. McDermott, B. Yа. Alekseev and Cristina Suárez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Marek Ziobro

36 papers receiving 450 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

2021 183 citations David F. McDermott, Jae‐Lyun Lee et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marek Ziobro Poland	11	277	267	196	130	58	46	457
Yasser Ged United States	12	212 0.8×	361 1.4×	244 1.2×	169 1.3×	87 1.5×	59	549
Pauline du Rusquec France	10	225 0.8×	160 0.6×	93 0.5×	66 0.5×	37 0.6×	25	400
Angelika Terbuch Austria	13	172 0.6×	159 0.6×	149 0.8×	103 0.8×	120 2.1×	33	397
Niels Viggo Jensen Denmark	11	190 0.7×	234 0.9×	119 0.6×	99 0.8×	101 1.7×	29	380
Chukwuemeka Ikpeazu United States	9	189 0.7×	144 0.5×	119 0.6×	65 0.5×	42 0.7×	23	356
Craig Norton United States	7	267 1.0×	223 0.8×	66 0.3×	88 0.7×	66 1.1×	11	370
Hillary E. Mulvey United States	5	299 1.1×	382 1.4×	257 1.3×	121 0.9×	39 0.7×	10	528
Cláudia Casanova Italy	9	273 1.0×	267 1.0×	100 0.5×	128 1.0×	62 1.1×	24	421
Laure Hirsch France	9	297 1.1×	246 0.9×	183 0.9×	116 0.9×	45 0.8×	16	517
Annelies Verbiest Belgium	11	138 0.5×	242 0.9×	177 0.9×	116 0.9×	58 1.0×	32	386

Countries citing papers authored by Marek Ziobro

Since Specialization

Citations

This map shows the geographic impact of Marek Ziobro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Ziobro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Ziobro more than expected).

Fields of papers citing papers by Marek Ziobro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Ziobro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Ziobro. The network helps show where Marek Ziobro may publish in the future.

Co-authorship network of co-authors of Marek Ziobro

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Ziobro. A scholar is included among the top collaborators of Marek Ziobro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Ziobro. Marek Ziobro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Püsküllüoğlu, Mirosława, Anna Polakiewicz-Gilowska, Iveta Selingerová, et al.. (2025). 566P Effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer: A real-world retrospective cohort study from central Europe. Annals of Oncology. 36. S419–S419.

Püsküllüoğlu, Mirosława, Manuela Las‐Jankowska, Joanna Streb, et al.. (2024). Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study. Oncology and Therapy. 12(4). 787–801. 2 indexed citations

Danielewicz, Iwona, et al.. (2024). Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study. Journal of Gynecologic Oncology. 36(2). e23–e23. 1 indexed citations

Püsküllüoğlu, Mirosława, et al.. (2024). Advanced renal cancer as a chronic disease — long-term disease control with a tyrosine kinase inhibitor (TKI) inhibitor. SHILAP Revista de lepidopterología. 74(5). 337–337.

Duchnowska, Renata, Jolanta Smok-Kalwat, Katarzyna Pogoda, et al.. (2024). Real-world treatment outcomes in patients with HR+ HER2- advanced breast cancer treated with CDK4/6 inhibitors and endocrine therapy.. Journal of Clinical Oncology. 42(16_suppl). 1067–1067. 1 indexed citations

Püsküllüoğlu, Mirosława, Joanna Streb, Renata Pacholczak‐Madej, et al.. (2024). Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study. Acta Oncologica. 63. 620–635.

Püsküllüoğlu, Mirosława, et al.. (2024). Unexpected outcomes in the treatment of a patient with metastatic melanoma and immune-related hemophagocytic lymphohistiocytosis. Polskie Archiwum Medycyny Wewnętrznej. 135(2).

Püsküllüoğlu, Mirosława, Renata Pacholczak‐Madej, Anna Mucha-Małecka, et al.. (2023). Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography (cT) and Pathology (pT) in a Multicenter Series of Breast Metaplastic Carcinoma Patients. Cancers. 16(1). 188–188. 1 indexed citations

Pacholczak‐Madej, Renata, Mirosława Püsküllüoğlu, Manuela Las‐Jankowska, et al.. (2022). Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience. Biomedicines. 10(10). 2528–2528. 5 indexed citations

10.

Niemiec, Joanna, Beata Sas-Korczyńska, Mirosława Püsküllüoğlu, et al.. (2022). Adjuvant combined therapy with trastuzumab in patients with HER2-positive breast cancer and cardiac alterations: implications for optimal cardio-oncology care. Polskie Archiwum Medycyny Wewnętrznej. 132(4). 6 indexed citations

11.

Pacholczak‐Madej, Renata, et al.. (2022). Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy. SHILAP Revista de lepidopterología. 123(1). 35–42. 6 indexed citations

12.

Püsküllüoğlu, Mirosława, Agnieszka Adamczyk, Anna Mucha-Małecka, et al.. (2022). Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion – An experience of a cancer reference centre in Poland. European Journal of Cancer. 178. 234–242. 11 indexed citations

13.

McDermott, David F., Jae‐Lyun Lee, Marek Ziobro, et al.. (2021). Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology. 39(9). 1029–1039. 183 indexed citations breakdown →

14.

Püsküllüoğlu, Mirosława, et al.. (2021). Primary cardiac atrial sarcomas. Report of two histologically different cases and review of the literature. Polish Journal of Pathology. 72(4). 358–369. 4 indexed citations

15.

Biesaga, Beata, Anna Janecka, Anna Mucha-Małecka, et al.. (2021). Low frequency of HPV positivity in breast tumors among patients from south-central Poland. Infectious Agents and Cancer. 16(1). 67–67. 5 indexed citations

16.

Niemiec, Joanna, Agnieszka Adamczyk, Aleksandra Ambicka, et al.. (2017). Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.. PubMed Central. 9(3). 1435–1447. 11 indexed citations

17.

Ługowska, Iwona, et al.. (2012). Stage III/IV Melanoma in Poland: epidemiology, standard of care and treatment related costs. 41–47. 4 indexed citations

18.

Ziobro, Marek, et al.. (2008). Effects of palliative treatment with temozolomide in patients with high-grade gliomas.. PubMed. 42(3). 210–5. 5 indexed citations

19.

Drosik, Kazimierz, Maciej Krzakowski, Krzysztof Krzemieniecki, et al.. (2006). Bisfosfoniany w zapobieganiu i kontroli zdarzeń kostnych u chorych z przerzutami nowotworów złośliwych do kości. Via Medica Journals. 2(4). 152–164.

20.

Pawlicki, Marek & Marek Ziobro. (2003). The advances in melanoma treatment. Contemporary Oncology/Współczesna Onkologia. 5(6). 260–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact